Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Zymeworks Inc (ZYME)

29.98   -0.31 (-1.02%) 08-13 16:00
Open: 30.17 Pre. Close: 30.29
High: 31.04 Low: 29.81
Volume: 494,220 Market Cap: 1,368M
Zymeworks Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer. The company's lead product candidates include ZW25, a bispecific antibody that is in Phase I and Phase II clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and other tumors; and ZW49, a bispecific antibody-drug conjugate that is in Phase I clinical trial for the treatment of advanced or metastatic HER2-expressing cancers. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; and BeiGene, Ltd. It also has licensing and research collaboration with LEO Pharma A/S to discover and develop bispecific antibodies; and collaboration with Applied BioMath, LLC. Zymeworks Inc.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 31.128 - 31.3 31.3 - 31.44
Low: 29.284 - 29.525 29.525 - 29.721
Close: 29.626 - 29.983 29.983 - 30.273

Technical analysis

as of: 2020-08-13 4:40:01 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 38.25     One year: 40.95
Support: Support1: 29.00    Support2: 24.13
Resistance: Resistance1: 32.75    Resistance2: 35.06
Pivot: 30.63
Moving Average: MA(5): 30.45     MA(20): 30.87
MA(100): 35.15     MA(250): 35.87
MACD: MACD(12,26): -0.94     Signal(9): -1.07
Stochastic oscillator: %K(14,3): 33.24     %D(3): 39.64
RSI: RSI(14): 40.24
52-week: High: 52.75  Low: 20.33  Change(%): 13.6
Average Vol(K): 3-Month: 42857  10-Days: 27710

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ZYME has closed above bottom band by 28.9%. Bollinger Bands are 55.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to ZYME's normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 07 Aug 2020
Wall street estimates Earnings report Zymeworks (NYSE:ZYME) - Stock Market Daily

Thu, 06 Aug 2020
Benzinga's Top Upgrades, Downgrades For August 6, 2020 - Benzinga

Thu, 06 Aug 2020
Is a Surprise Coming for Zymeworks (ZYME) This Earnings Season? - Nasdaq

Wed, 05 Aug 2020
Zymeworks Inc. (ZYME) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Wed, 05 Aug 2020
Zymeworks Reports 2020 Second Quarter Financial Results - Business Wire

Fri, 31 Jul 2020
Zymeworks Inc. (ZYME) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 46
Shares Float (M) 36
% Held by Insiders 10.12
% Held by Institutions 60.11
Shares Short (K) 2,240
Shares Short P. Month (K) 1,170

Stock Financials

EPS -3.870
EPS Est This Year -2.980
EPS Est Next Year -2.540
Book Value (p.s.) 11.470
Profit Margin
Operating Margin -664.31
Return on Assets (ttm) -24.6
Return on Equity (ttm) -47.1
Qtrly Rev. Growth -30.7
Gross Profit (p.s.) -1.896
Sales Per Share 0.569
EBITDA (p.s.) -3.712
Qtrly Earnings Growth
Operating Cash Flow (M) -98
Levered Free Cash Flow (M) -34

Stock Valuations

PE Ratio -7.75
PEG Ratio
Price to Book value 2.61
Price to Sales 52.73
Price to Cash Flow -13.93

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.